Currencies / SNY
SNY: Sanofi - American Depositary Shares
49.48
USD
0.46
(0.92%)
SNY exchange rate has changed by -0.92% for today. During the day, the instrument was traded at a low of 49.25 and at a high of 49.74.
Follow Sanofi - American Depositary Shares dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
SNY News
- AbbVie Smashes Earnings, Bets Big On Depression Drug Bretisilocin
- Will Weak Gardasil Sales Continue to Be a Drag on MRK's Top Line?
- BofA downgrades Novavax stock on vaccine uncertainty
- Macquarie Small Cap Core Fund Q2 2025 Commentary
- Recursion: "Hold" Rating Based On Initial REC-4881 FAP Treatment Data (NASDAQ:RXRX)
- Columbia Pyrford International Stock Fund Q2 2025 Commentary (Mutual Fund:PISOX)
- Macquarie Smid Cap Core Fund Q2 2025 Commentary
- Solar, biotech, and health insurance stocks are moving on Friday: here's why
- Can Eylea HD and Dupixent Profits Revive Regeneron Stock?
- SNY's Rilzabrutinib Gets EU Orphan Drug Tag for IgG4-Related Disease
- H.C. Wainwright lowers Adagene stock price target to $7 on development path clarity
- BNY Mellon Global Equity Income Fund Q2 2025 Commentary
- Bicycle Therapeutics stock price target lowered to $10 at Citizens JMP
- Sanofi halts Praluent supply in China due to limited availability
- Sanofi, Eli Lilly, Novo Nordisk, AstraZeneca Face Renewed Claims Of Conspiring To Restrict 340B Discounts - AstraZeneca (NASDAQ:AZN), Novo Nordisk (NYSE:NVO), Eli Lilly (NYSE:LLY), Sanofi (NASDAQ:SNY)
- AstraZeneca: Great Portfolio, But Not A Great Price (NASDAQ:AZN)
- Bicycle Therapeutics stock price target raised to $27 from $25 at RBC Capital
- Kymera Q2 2025 slides: Strong pipeline advances despite revenue decline
- Recordati shares rise after Jefferies upgrade to “buy” on growth prospects
- Arrowhead Pharma stock price target lowered to $21 at Leerink Partners
- Chardan Capital lowers SAB Biotherapeutics stock price target to $12 from $20
- This Monster Beverage Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday - Monster Beverage (NASDAQ:MNST), LegalZoom.com (NASDAQ:LZ)
- JPMorgan upgrades Sanofi stock rating to Overweight on favorable pipeline outlook
- Ariel International Fund Q2 2025 Commentary
Daily Range
49.25
49.74
Year Range
44.73
59.73
- Previous Close
- 49.94
- Open
- 49.40
- Bid
- 49.48
- Ask
- 49.78
- Low
- 49.25
- High
- 49.74
- Volume
- 5.823 K
- Daily Change
- -0.92%
- Month Change
- 7.61%
- 6 Months Change
- -12.07%
- Year Change
- -14.35%
30 August, Saturday